Bradycardia resident survival guide: Difference between revisions

Jump to navigation Jump to search
Line 42: Line 42:


{{Family tree/start}}
{{Family tree/start}}
{{family tree | | | | V01 | | | | | | | | | | | | | | | | | | |V01= <div style="float: left; text-align: left; line-height: 150% ">'''Characterize the symptoms:''' <br>
{{family tree | | | | V01 | | | | | | | | | | | | | | | | | | |V01= <div style="float: left; text-align: left; line-height: 150% ">'''Characterize the symptoms:''' <br>
❑ [[Palpitations]] <br> ❑ [[Lightheadedness]] <br> ❑ [[Dyspnea]] <br> ❑ [[Chest pain]] <br> ❑ [[Altered mental status]] </div> }}
❑ [[Palpitations]] <br> ❑ [[Lightheadedness]] or [[Dizziness]] <br> ❑ [[Dyspnea]] <br> ❑ [[Chest pain]] <br> ❑ [[Altered mental status]] <br>
❑ [[Syncope]] <br> ❑ [[Fatigue]] <br> ❑ [[Exercise intolerance]]
----
'''Obtain a detailed history''': <br>
❑ [[Age]] <br> :: ❑ More common in elderly or older patients due to: <br>
♦ Disease in the sinus node <br> ♦ AV nodal disease <br> ♦ Age-related fibrosis and sclerosis <br> ❑ Medication use <br> :: ❑ [[Beta blockers]] <br> :: ❑ [[Calcium channel blockers]] <br> :: ❑ [[Digoxin]] <br> ❑ Past medical history <br> :: ❑ [[Infection]] <br> :: ❑ Infiltrative disease <br> :: ❑ [[Increased intracranial pressure]] <br> :: ❑ [[Electrolyte disturbance]] <br> :: ❑ Toxin exposure <br> :: ❑ [[Surgery]] <br> :: ❑ [[Heart transplant]] <br> :: ❑ [[Sleep apnea]] <br> :: ❑ [[Myocardial infarction]] <br> :: ❑ [[Hypothyroidism]] <br> </div>}}
{{family tree | | | | |!| | | | | | | | | | | | | | | | | | | | }}
{{family tree | | | | |!| | | | | | | | | | | | | | | | | | | | }}
{{Family tree | | | | A01 | | | |A01=<div style="float: left; text-align: left; line-height: 150% ">'''Examine the patient''': <br>
{{Family tree | | | | A01 | | | |A01=<div style="float: left; text-align: left; line-height: 150% ">'''Examine the patient''': <br>

Revision as of 16:53, 20 March 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]: Associate Editor(s)-in-Chief: Ogheneochuko Ajari, MB.BS, MS [2]; Vidit Bhargava, M.B.B.S [3]

Overview

Bradycardia is defined as a sinus rhythm with a rate <60 beats per minute. A heart rate of <50 beats per minute is used as a working definition of bradycardia causing symptoms.[1]

Causes

Life Threatening Causes

Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.

Common Causes

Management

Shown below is an algorithm depicting the management of bradycardia based on the 2010 AHA guidelines for cardiopulmonary resuscitation and emergency cardiovascular care.[1]

 
 
 
Characterize the symptoms:

Palpitations
Lightheadedness or Dizziness
Dyspnea
Chest pain
Altered mental status
Syncope
Fatigue
Exercise intolerance


Obtain a detailed history:
Age
 :: ❑ More common in elderly or older patients due to:

♦ Disease in the sinus node
♦ AV nodal disease
♦ Age-related fibrosis and sclerosis
❑ Medication use
 :: ❑ Beta blockers
 :: ❑ Calcium channel blockers
 :: ❑ Digoxin
❑ Past medical history
 :: ❑ Infection
 :: ❑ Infiltrative disease
 :: ❑ Increased intracranial pressure
 :: ❑ Electrolyte disturbance
 :: ❑ Toxin exposure
 :: ❑ Surgery
 :: ❑ Heart transplant
 :: ❑ Sleep apnea
 :: ❑ Myocardial infarction
 :: ❑ Hypothyroidism
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Examine the patient:

❑ Heart rate < 50/min
❑ Signs of increased work of breathing

Tachypnea
♦ Intercostal retractions
♦ Suprasternal retractions
♦ Paradoxical abdominal breathing

❑ Signs of poor perfusion

Hypotension
♦ Signs of shock
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Identify and treat underlying cause:

❑ Maintain patent airway; assist breathing as necessary
❑ Oxygen (if hypoxemic)
❑ Cardiac monitor to identify rhythm
❑ Monitor blood pressure and oximetry
❑ IV access

❑ 12-lead ECG if available; don’t delay therapy
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Persistent bradyarrhythmia causing:
Hypotension?
❑ Acutely altered mental status?
❑ Signs of shock?
Ischemic chest discomfort?
❑ Acute heart failure?
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes
 
 
 
No
 
 
 
 
 
 
 
 
 
 
 
 
Atropine
❑ Administer a first dose 0.5 mg IV bolus
❑ Repeat every 3-5 minutes
❑ Administer a maximum dose of 3 mg
 
 
 
❑ Monitor and observe
 
 
 
 
 
 
 
 
 
 
 
If atropine ineffective:
❑ Proceed with transcutaneous pacing, OR
❑ Administer dopamine infusion (2-10 mcg/kg/min), OR
❑ Administer epinephrine infusion (2-10 mcg/min)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
❑ Consider expert consultation
❑ Consider transvenous pacing
 
 
 
 
 
 

Do's

  • Prepare for transcutaneous pacing if perfusion is poor.
  • Consider using sodium bicarbonate for severe metabolic acidosis.
  • Use atropine with caution in the presence of myocardial ischemia because it increases oxygen demand and could worsen the ischemia.

Don'ts

  • Do not delay pacing if the rhythm is Mobitz type II second degree block or third-degree AV block even if the patient is asymptomatic.
  • Avoid using atropine in hypothermic patients with either bradycardia or Mobitz type II second degree AV block.
  • Do not use atropine to treat bradycardia in cardiac transplant patients.
  • Do not use atropine to treat Type II second degree and third degree heart blocks since their management requires transcutaneous/transvenous pacing.

References

  1. 1.0 1.1 Neumar, RW.; Otto, CW.; Link, MS.; Kronick, SL.; Shuster, M.; Callaway, CW.; Kudenchuk, PJ.; Ornato, JP.; McNally, B. (2010). "Part 8: adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care". Circulation. 122 (18 Suppl 3): S729–67. doi:10.1161/CIRCULATIONAHA.110.970988. PMID 20956224. Unknown parameter |month= ignored (help)

Template:WH Template:WS